HT
HOPE-Neuron Therapeutx, Inc.
SEC filingBiotechnology · Phoenix, AZ
Amount raised$150Ksold at filing
Total offering$150K
Investors in the raise1count reported to the SEC
FiledJul 2, 2026first sale Jun 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ronald Howard LaneExecutive Officer
John Howard LoufExecutive Officer
Karina Howard FedaszExecutive Officer
Mark Howard ForneyExecutive Officer
Executive officers, directors and promoters as listed on the Form D.